ArticleJournal for immunotherapy of cancer2021

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.

Robert H Vonderheide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.